These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19190802)

  • 21. Thrombotic microangiopathy: a challenge with uncertain outcome.
    Kulzer P; Wanner C
    Nephrol Dial Transplant; 1998 Aug; 13(8):2154-60. PubMed ID: 9719191
    [No Abstract]   [Full Text] [Related]  

  • 22. New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Raife T; Montgomery R
    Rev Clin Exp Hematol; 2001 Sep; 5(3):236-61; discussion 311-2. PubMed ID: 11703817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemostasis and the kidneys (I)].
    Savitskiĭ SN; Gordeev AV
    Ter Arkh; 1992; 64(6):97-100. PubMed ID: 1440352
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal involvement in thrombotic microangiopathies.
    Churg J; Strauss L
    Semin Nephrol; 1985 Mar; 5(1):46-56. PubMed ID: 3843782
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical aspects of endotheliotropic (hemolytic) nephroangiopathy].
    Renner E; Cohen S
    Verh Dtsch Ges Pathol; 1989; 73():169-80. PubMed ID: 2482603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study.
    Sucker C; Kurschat C; Farokhzad F; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2009; 15(3):283-8. PubMed ID: 19448163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemolytic-uremic syndrome in adults].
    Cacoub P; Deray G; Eugène M; Achour L; Baumelou A
    Presse Med; 1987 Mar; 16(11):527, 530-2. PubMed ID: 2951691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvascular thrombosis: pathophysiology and new strategies.
    Wu KK
    Hosp Pract (Off Ed); 1985 May; 20(5):47-55. PubMed ID: 3932436
    [No Abstract]   [Full Text] [Related]  

  • 29. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
    Fakhouri F; Frémeaux-Bacchi V
    Nat Clin Pract Nephrol; 2007 Dec; 3(12):679-87. PubMed ID: 18033227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of thrombotic microangiopathy: insights from animal models.
    Richards A; Kavanagh D
    Nephron Exp Nephrol; 2009; 113(4):e97-103. PubMed ID: 19684414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal thrombotic microangiopathy].
    Sakakibara K
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):316-9. PubMed ID: 9277751
    [No Abstract]   [Full Text] [Related]  

  • 32. [Renal pathology of thromobotic microangiopathy].
    Mii A; Shimizu A
    Nihon Jinzo Gakkai Shi; 2014; 56(7):1031-42. PubMed ID: 25420403
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of hemostasis and erythrocyte changes in thrombohemolytic microangiopathies].
    Breddin K
    Med Welt; 1975 Jun; (23):1118-22. PubMed ID: 1171348
    [No Abstract]   [Full Text] [Related]  

  • 34. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy.
    Gordon LI; Kwaan HC; Rossi EC
    Semin Hematol; 1987 Jul; 24(3):194-201. PubMed ID: 3659948
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombotic microangiopathy].
    Perkowska-Ptasińska A
    Pol J Pathol; 2011 Jun; 62(2 Suppl 1):s82-9. PubMed ID: 23120834
    [No Abstract]   [Full Text] [Related]  

  • 36. The kidney in hematologic disease. A review.
    Barakat AY; Noubani H
    Int J Pediatr Nephrol; 1986; 7(4):207-12. PubMed ID: 3546173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of endothelial damage in thrombotic microangiopathy].
    Ruiz-Torres MP; Casighari F; Noris M; Macconi D; Galbusera M; Remuzzi G
    Nefrologia; 2003; 23 Suppl 3():25-7. PubMed ID: 12901188
    [No Abstract]   [Full Text] [Related]  

  • 38. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies.
    Sucker C; Kurschat C; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Ostojic L; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2009; 15(3):360-3. PubMed ID: 19448164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic microangiopathies.
    Halevy D; Radhakrishnan J; Markowitz G; Appel G
    Crit Care Clin; 2002 Apr; 18(2):309-20, vi. PubMed ID: 12053836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic microangiopathy and intravenous immunoglobulin therapy.
    Watanabe T
    Pediatr Nephrol; 2007 Jun; 22(6):907-8; author reply 909. PubMed ID: 17295029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.